ClinicalTrials.Veeva

Menu

A Smoke-Free Home Intervention in Tribal Communities

Emory University logo

Emory University

Status

Enrolling

Conditions

Tobacco-Related Carcinoma

Treatments

Other: Best Practice
Other: Survey Administration
Behavioral: Smoking Cessation Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06583148
R01CA268024 (U.S. NIH Grant/Contract)
P30CA138292 (U.S. NIH Grant/Contract)
NCI-2024-06174 (Registry Identifier)
RSPH6261-24 (Other Identifier)
STUDY00006459 (Other Identifier)

Details and patient eligibility

About

This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.

Full description

PRIMARY OBJECTIVE:

I. To assess the effectiveness of a smoke-free homes intervention for tribal communities.

OUTLINE: Participants are randomized to 1 of 2 groups.

GROUP I: Participants receive the smoke-free home program, consisting of mailed educational information about smoke-free homes at enrollment and in weeks 4 and 6, and attend one coaching call in week 2.

GROUP II: Participants receive usual care on study. Participants may optionally receive the smoke-free home program following the 6 months follow-up.

After completion of study intervention, participants are followed up at 3 and 6 months.

Enrollment

575 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years of age and older
  • Self-report as being a smoker or living with a smoker
  • Indicate that they do not reside in a smoke-free home
  • Identify as living in an American Indian household

Exclusion criteria

  • Children under the age of 18 will not be included

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

575 participants in 2 patient groups

Group I (smoke-free home program)
Experimental group
Description:
Participants receive the smoke-free home program, consisting of mailed educational information about smoke-free homes at enrollment and in weeks 4 and 6, and attend one coaching call in week 2.
Treatment:
Behavioral: Smoking Cessation Intervention
Other: Survey Administration
Group II (waitlist control)
Active Comparator group
Description:
Participants receive usual care on study. Participants may optionally receive the smoke-free home program following the 6 months follow-up.
Treatment:
Other: Survey Administration
Other: Best Practice

Trial contacts and locations

1

Loading...

Central trial contact

Josh Kaufmann

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems